Table 1.
Study (Year) | Country | Setting | Age (y, Mean ± SD) | Total Study Population | Data Source | Diagnostic Test | Prevalence of Fruit Allergy | Leading Types of Fruit (N, % of Total Study Population) |
---|---|---|---|---|---|---|---|---|
East Asia | ||||||||
Feng (2023) [6] | China (Jiangxi) | Community-based | 44.72 ± 12.91 | 11,935 | Self-reported | NA | NR |
|
Feng (2022) [7] | China (Jiangxi) | Community-based | 8.67 ± 1.26 | 8856 | Parent-reported | NA | NR |
|
Sha (2019) [8] | China (Beijing) | Community-based | 0–14 * | 13,073 | Parent-reported | NA | 1.5% | NR |
Zeng (2015) [9] | China (Guangdong) | Community-based | 4.6 ± 1.1 | 2540 | Parent-reported | NA | NR |
|
Kaneko (2015) [10] | Japan (Kawasaki) | Community-based | 0–5 * | 23,969 | Physician-diagnosed | NR | 0.24% | NR |
Lee (2017) [11] | South Korea (Suwon) | Hospital-based | 38.5 ± 14.1 | 95 † | Physician-diagnosed | SPT, sIgE | 26 ¶ | NR |
Kim (2017) [12] | South Korea (Nationwide) | Community-based | 6–16 * | 29,842 | Parent-reported | NA | 1.41% | NR |
Su (2023) [13] | Taiwan (Taipei) | Community-based | 6–7 *, 13–14 *, and Adult [Median (IQR) 42 (39–46)] | 16,200 | Parent-reported and self-reported | NA | 6–7 y: 0.96% 13–14 y: 1.16% Adult: 0.79% Overall: 0.89% |
NR |
Li (2022) [1] | Taiwan (Nationwide) | Community-based | Mean (range) 10.1 (6–13) |
9982 | Parent-reported and self-reported | NA | 5.6% |
|
Southeast Asia | ||||||||
Sompornrattanaphan (2023) [14] | Thailand (Bangkok) | Hospital-based | Median (IQR) 31.0 (24.0, 44.0) |
711 | Physician-diagnosed | SPT, sIgE, OFC | 2.11% |
|
South Asia | ||||||||
Mahesh (2016) [15] | India (Bangalore, Mysore) | Community-based | 20–54 * | 10,931 | Self-reported and physician-diagnosed | sIgE | NR |
|
West Asia | ||||||||
Ahanchian (2016) [16] | Iran (Khorasan) | Hospital-based | Mean(range) 5.34 (0–18) |
NR | Physician-diagnosed | SPT | 371 ¶ |
|
Nachshon (2019) [17] | Israel (Recruitment center of the Israel Defense Forces) | Community-based | 17 | 12,592 | Self-reported and physician-diagnosed | SPT, OFC | NR |
|
Irani (2015) [18] | Lebanon | Community-based | NR (infants, children, and adults) | 506 | Self-reported | NA | 2.57% |
|
Alotiby (2022) [19] | Saudi Arabia (Makkah) | Community-based | 18–80 * | 531 | Self-reported | NA | 7% | NR |
Akarsu (2021) [20] | Turkey (Ankara) | Hospital-based | Median (IQR) 6 (5–7.63) |
534† | Physician-diagnosed | SPT, sIgE, OFC | NR | 3–5 y (n = 440):
6–12 y (n = 217):
13–18 y (n = 35):
|
Kaya (2013) [21] | Turkey (Ankara) | Community-based | 12.9 ± 0.9 | 10,096 | Parent-reported and physician-diagnosed | SPT, sIgE, OFC | 0.029% |
|
Europe | ||||||||
Tamazouzt (2022) [22] | France (Nationwide) | Community-based, birth cohort | 0–5.5 * | 16,400 | Parent-reported | NA | NR |
|
Röhrl (2022) [23] | Germany | Community-based | 0–2 * | KUNO Kids cohort 1139 |
Parent-reported | NA | NR |
|
SPATZ cohort 1006 |
Physician-diagnosed | NR | NR | NR | ||||
Lozoya-Ibáñez (2020) [24] | Portugal (Central region) | Community-based | 14.3 ± 1.1 | 1702 | Self-reported and physician-diagnosed | SPT, sIgE, OFC | 0.47% | NR |
Lozoya-Ibáñez (2016) [25] | Portugal (Central region) | Community-based | Mean(range) 48 (18–80) |
965 | Self-reported and physician-diagnosed | SPT, sIgE, OFC | 0.1% | NR |
Oceania | ||||||||
Sasaki (2017) [26] | Australia | Community-based | 10–14 * | 9816 | Parent-reported and Physician-diagnosed | SPT, sIgE, OFC | NR | Clinic group ※
Self-reported FA ※
|
North America | ||||||||
Singer (2021) [27] | Canada | Hospital-based (Primary care) | ≤19 | 288,490 | Physician-diagnosed | NR | 0.2% | NR |
Bedolla-Pulido (2019) [28] | Mexico (Guadalajara) | Community-based | 15–18 * | 1992 | Self-reported | NA | NR |
|
Ontiveros (2016) [29] | Mexico (Culiacan) | Community-based | 8.6 (5–13) | 1049 | Parent-reported | NA | NR |
|
Puente-Fernández (2016) [30] | Mexico (Toluca) | Community-based | 18–25 | 1200 | Self-reported | NA | 8% |
|
Verril (2015) [31] | United States | Community-based | ≥18 | 4568 | Self-reported | NA | 2.7% ‡ | NR |
South America | ||||||||
da S. Correia (2022) [32] | Brazil (Limoeiro town, Pernambuco state) | Community-based | 3.6 ± 1.1 | 412 | Parent-reported | NA | 1.9% |
|
Silva (2016) [33] | Brazil (Uberlandia) | Community-based | 18–65 * | 1583 | Self-reported | NA | 1.6% |
|
Hoyos-Bachiloglu (2014) [34] | Chile (Santiago) | Community-based | ~5, 10, 15 | 455 | Parent-reported | NA | NR |
|
Beltrán-Cárdenas (2021) [35] | Colombia (Medellín) | Community-based | 5–12 * | 969 | Self-reported | NA | 1.13% |
|
Note: Studies were stratified by continents and arranged according to alphabetical order of country’s name, and year of publication. Prevalence was either reported directly from each study or calculated as a percentage using the reported data on food or fruit allergy/hypersensitivity divided by the total study population, unless otherwise specified. Abbreviations: FA, food allergy; IQR, interquartile range; NA, not available; NR, not reported; OFC, oral food challenge; SD, standard deviation; sIgE, serum specific immunoglobulin E; SPT, skin prick test; y, year. * Range; ¶ Number of fruit-allergic patients; † Number of food-allergic patients; § Percentage per food-allergic patients; ‡ Weighted prevalence; ※ Clinic group (n = 5016) consisted of students who had a parent-reported questionnaire, with successful phone contact and completion of clinic evaluation. Self-reported group (n = 4800) consisted of the remaining students, who had a student questionnaire only or parent-reported questionnaire but without nurse contact or completion of clinic evaluation.